Deferred Stenting for Heavy Thrombus Burden During Percutaneous Coronary Intervention for ST-Elevation MI

Akshyaya Pradhan1, Monika Bhandari1, Pravesh Vishwakarma1

  • 1Department of Cardiology, King George's Medical University Lucknow, India.

European Cardiology
|April 26, 2021
PubMed

Insights

Deferred stenting after prolonged anticoagulation may reduce infarct size in select ST-elevation MI patients with large thrombus burdens. This strategy aims to mitigate slow-flow/no-reflow phenomena and improve cardiovascular outcomes.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Acute Coronary Syndromes

Background:

  • ST-elevation MI (STEMI) often presents with significant thrombus burden.
  • Primary percutaneous coronary intervention with stenting can trigger slow-flow/no-reflow, increasing periprocedural MI risk.
  • Deferred stenting is explored to reduce thrombus burden and mitigate these risks.

Purpose of the Study:

  • To evaluate the safety and feasibility of deferred stenting after 5 days of anticoagulation in a STEMI patient with a large thrombus.
  • To review existing literature on deferred stenting strategies in STEMI.
  • To propose a clinical algorithm for implementing deferred stenting.

Main Methods:

  • Case report of a 45-year-old smoker with STEMI and large thrombus.
  • Review of registries, trials, and meta-analyses on deferred stenting.
  • Analysis of benefits and harms of the deferred stenting strategy.

Main Results:

  • The case demonstrated safety and feasibility of deferred stenting post-anticoagulation.
  • Literature review suggests potential benefits in properly selected patients.
  • Analysis highlights the need for careful patient selection to maximize benefits and minimize harms.

Conclusions:

  • Deferred stenting, particularly after prolonged anticoagulation, shows promise for reducing infarct size in selected STEMI patients.
  • A tailored approach based on thrombus burden and patient factors is crucial.
  • An evidence-based algorithm can guide clinical decision-making for deferred stenting.

Related Concept Videos

Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
96
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
242
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
74
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
105
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
96
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
91